ClinicalTrials.gg
WithdrawnNCT05224479Updated Nov 1, 2022

Clinical Validation of Machine Learning Triage of Chest Radiographs

An interventional study of Traditional workflow triage and Machine learning workflow triage in Chest--Diseases, sponsored by Stanford University. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-01.

Sponsored by Stanford University · Not applicable, Interventional, and Diagnostic

Why this study was withdrawn
Change in research plan
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Artificial intelligence and machine learning have the potential to transform the practice of radiology, but real-world application of machine learning algorithms in clinical settings has been limited. An area in which machine learning could be applied to radiology is through the prioritization of unread studies in a radiologist's worklist. This project proposes a framework for integration and clinical validation of a machine learning algorithm that can accurately distinguish between normal and abnormal chest radiographs. Machine learning triage will be compared with traditional methods of study triage in a prospective controlled clinical trial. The investigators hypothesize that machine learning classification and prioritization of studies will result in quicker interpretation of abnormal studies. This has the potential to reduce time to initiation of appropriate clinical management in patients with critical findings. This project aims to provide a thoughtful and reproducible framework for bringing machine learning into clinical practice, potentially benefiting other areas of radiology and medicine more broadly.

02

Conditions studied

  • Chest--Diseases
03

In context

Lead sponsor

Stanford University is the lead sponsor of 2,162 studies on the registry; 429 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Radiologist at Stanford Hospital and Clinics

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Traditional workflow triage

    Radiologists follow standard triage of chest radiographs.

    Other: Traditional workflow triage · Other: Machine learning workflow triage · Other: Random workflow triage

  • Active comparator
    Machine learning workflow triage

    Radiologists follow machine learning triage of chest radiographs.

    Other: Traditional workflow triage · Other: Machine learning workflow triage · Other: Random workflow triage

  • Sham comparator
    Random workflow triage

    Radiologists follow randomly ordered triage of chest radiographs.

    Other: Traditional workflow triage · Other: Machine learning workflow triage · Other: Random workflow triage

Interventions

  • OtherTraditional workflow triage

    Workflow triage is based on order location, STAT designation, and first-in-first-out status.

  • OtherMachine learning workflow triage

    Workflow triage is based on the machine learning model's confidence of abnormality.

  • OtherRandom workflow triage

    Workflow triage is based on random order.

06

What researchers measure

Primary outcomes

  1. Turnaround time

    Time from completion of radiograph to time that radiologist issues an assessment via preliminary or final report

    Time frame: up to 1 hour

07

Study locations

1 site
  • Stanford University
    Stanford, California 94305, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05224479
Collaborators
Society of Thoracic Radiology
Responsible party
Emily Tsai (Clinical Assistant Professor, Stanford University) — Principal investigator
First posted
Feb 4, 2022
Start date
Aug 2022 (estimated)
Primary completion
Nov 2022 (estimated)
Completion
Nov 2022 (estimated)
Last update
Nov 1, 2022

Study contacts

Emily Tsai, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion